N. Lynn Henry

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.165Author DataRank

Indexed papers

8in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 8 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Disparities in diagnosis and management of chronic overlapping pain conditions in an observational study of medicare beneficiaries

Journal of Pain(2025)10.1016/j.jpain.2025.105490

Top 70%

0.165DataRank

Top 70%2 citations

Teresa P E Knecht, Madison N. Irwin, Vincent D. Marshall, N. Lynn Henry, Karen B. Farris +1 more

Papers

Driven by 65 papers — median percentile 0. Top paper: “Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain”.

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.41720

N/A

1.5DataRank · unranked

56 citations

Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke +5 more

Cardiovascular disease risk in long‐term breast cancer survivors: A population‐based cohort study

Cancer(2022)10.1002/cncr.34224

N/A

1.2DataRank · unranked

40 citations

Chun-Pin E. Chang, Bayarmaa Mark, Kerry Rowe, John Snyder, Mark Dodson +11 more

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7062

N/A

0.883DataRank · unranked

27 citations

Gary Zirpoli, William E. Barlow, G. Thomas Budd, Bryan McKiver, Lajos Pusztai +10 more

SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.10.003

N/A

0.736DataRank · unranked

24 citations

Hongli Li, Anne Beaven, Paolo F. Caimi, Leandro Cerchietti, Ash A. Alizadeh +9 more

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

Frontiers in Genetics(2021)10.3389/fgene.2021.662734

N/A

0.574DataRank · unranked

14 citations

Karen L. Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman +6 more

Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac166

N/A

0.553DataRank · unranked

39 citations

Susan K. Parsons, Patricia A. Ganz, Lynne I. Wagner, Pamela S. Hinds, Sarah Alexander +14 more

Survey of US Medical Oncologists' Practices and Beliefs Regarding DPYD Testing Before Fluoropyrimidine Chemotherapy

JCO Oncology Practice(2022)10.1200/op.21.00874

N/A

0.520DataRank · unranked

31 citations

Amy L. Pasternak, N. Lynn Henry, Vaibhav Sahai, Daniel L. Hertz, Kyoin Koo

A circadian and app-based personalized lighting intervention for the reduction of cancer-related fatigue

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102001

N/A

0.398DataRank · unranked

6 citations

Olivia Walch, Walter Dempsey, Kevin M. Hannay, Caroline Clingan, Zoe Bowen +8 more

TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer

JCO Precision Oncology(2024)10.1200/po.23.00724

N/A

0.345DataRank · unranked

9 citations

Cindy Matsen, Zhengtao Chu, Kenneth M. Boucher, Sandra D. Scherer, Satya S. Pathi +15 more

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2137

N/A

0.330DataRank · unranked

8 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer

Cancer Medicine(2025)10.1002/cam4.71117

N/A

0.273DataRank · unranked

5 citations

Elise A. Miller, Kelley M. Kidwell, Zeb R. Zacharias, Jon C. D. Houtman, Kelly Scheu +4 more

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Journal of Patient-Reported Outcomes(2020)10.1186/s41687-020-00220-x

N/A

0.269DataRank · unranked

5 citations

Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries +15 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps158

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG-GI004/SWOG-S1610).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps260

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

NRG-GI004/SWOG-S1610: Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps232

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04

Quality of Life Research(2024)10.1007/s11136-024-03746-5

N/A

0.225DataRank · unranked

3 citations

Jessica Roydhouse, Mourad Tighiouart, N. Lynn Henry, Sungjin Kim, Ron D. Hays +4 more

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

JNCI Cancer Spectrum(2025)10.1093/jncics/pkaf032

N/A

0.208DataRank · unranked

3 citations

Sungjin Kim, N. Lynn Henry, Ron D. Hays, Vinícius F. Calsavara, Michael Luu +11 more

Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy

JAMA Oncology(2026)10.1001/jamaoncol.2025.5549

N/A

0.208DataRank · unranked

3 citations

Michael J. Fisch, Salene M. W. Jones, N. Lynn Henry, Dawn L. Hershman, Joseph M. Unger

Determining the association of rurality and cardiovascular disease among prostate cancer survivors

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.06.008

N/A

0.208DataRank · unranked

3 citations

Brock O’Neil, Chun-Pin E. Chang, Bayarmaa Mark, John Snyder, Vikrant Deshmukh +7 more

Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-024-07523-3

N/A

0.165DataRank · unranked

2 citations

Cathee Till, N. Lynn Henry, Michael J. Fisch, Dawn L. Hershman, Joseph M. Unger +1 more

Socioeconomic deprivation and patient-reported outcomes in symptom management trials for patients with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.158

N/A

0.165DataRank · unranked

2 citations

Cathee Till, N. Lynn Henry, Michael Fisch, Dawn L. Hershman, Joseph M. Unger +1 more

Disparities in diagnosis and management of chronic overlapping pain conditions in an observational study of medicare beneficiaries

Journal of Pain(2025)10.1016/j.jpain.2025.105490

Top 70%

0.165DataRank

Top 70%2 citations

Teresa P E Knecht, Madison N. Irwin, Vincent D. Marshall, N. Lynn Henry, Karen B. Farris +1 more

Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12003

N/A

0.165DataRank · unranked

2 citations

Opeyemi A. Jegede, Victor T. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand +15 more

Examining uptake of electronic patient reported outcomes (ePRO) in a prospective study of immune-related adverse events (IR-AEs).

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.368

N/A

0.165DataRank · unranked

2 citations

Amy K. Darke, Krishna S. Gunturu, Dawn L. Hershman, Michael Fisch, N. Lynn Henry +2 more

Mammography Among Women Residing in Urban Versus Rural Utah: Breast Cancer Survival

Cancer Medicine(2024)10.1002/cam4.70505

N/A

0.104DataRank · unranked

1 citations

Chun-Pin E. Chang, Karen Curtin, James VanDerslice, Lisa H. Gren, Vikrant Deshmukh +6 more

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221

Cancer Chemotherapy and Pharmacology(2024)10.1007/s00280-024-04680-6

N/A

0.104DataRank · unranked

1 citations

Gary Zirpoli, G. Thomas Budd, William E. Barlow, Lajos Pusztai, Gabriel N. Hortobágyi +8 more

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221

Research Square(2023)10.21203/rs.3.rs-3242513/v1

N/A

0.104DataRank · unranked

1 citations

Gary Zirpoli, G. Thomas Budd, William E. Barlow, Lajos Pusztai, Gabriel N. Hortobágyi +8 more

Adverse health outcomes among rural prostate cancer survivors: A population-based study

Cancer Epidemiology(2023)10.1016/j.canep.2023.102430

N/A

0.104DataRank · unranked

1 citations

Chun-Pin E. Chang, Michael Newman, Vikrant Deshmukh, John Snyder, Ankita Date +6 more

Plasma proteomics to predict taxane-induced peripheral neuropathy

(2024)10.22541/au.172066987.71730545/v1

N/A

0DataRank · unranked

0 citations

Yaping Liu, N. Lynn Henry, Manjunath P. Pai, Hao‐Jie Zhu, Daniel L. Hertz +1 more

Capturing Chemotherapy and Radiotherapy Dose Among Breast Cancer Patients With the Utah All‐Payer Claims Database Compared With Gold‐Standard Abstraction

Cancer Medicine(2024)10.1002/cam4.70411

Top 100%

0DataRank

Top 100%0 citations

Chun-Pin E. Chang, Shane Lloyd, M.L. Dodson, Vikrant Deshmukh, Michael Newman +8 more

Rural–Urban Disparities in Cancer Care—Analyzing Routinely Collected Patient‐Reported Outcomes. A Cross‐Sectional Study

Cancer Medicine(2025)10.1002/cam4.70437

N/A

0DataRank · unranked

2 citations

Bayarmaa Mark, Krista Ocier, Emmanuel Adediran, Belinda Taylor, Kim Svoboda +5 more

A mixed-methods study characterizing experiences of medical oncologists’ use of gonadotropin-releasing hormone agonists for treatment of breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07734-2

N/A

0DataRank · unranked

1 citations

Bo Hu, Dinorah Martinez Tyson, Carley Geiss, Susan T. Vadaparampil, Heather Jim +5 more

Risks of adverse health outcomes among older rural prostate cancer survivors in the SEER‐Medicare data

The Journal of Rural Health(2025)10.1111/jrh.70029

N/A

0DataRank · unranked

1 citations

Daren Huang, Shane Lloyd, N. Lynn Henry, Brock O’Neil, Mia Hashibe +1 more

Analyses of adverse events and patient‐reported outcomes with the toxicity index in cancer clinical trials

Cancer(2025)10.1002/cncr.70086

N/A

0DataRank · unranked

1 citations

N. Lynn Henry, Hanna Bandos, Vinícius F. Calsavara, Reena S. Cecchini, Márcio A. Diniz +8 more

Incident mental disorders after breast cancer: A matched population-based cohort

Journal of Psychosomatic Research(2025)10.1016/j.jpsychores.2025.112108

Top 100%

0DataRank

Top 100%0 citations

Chun-Pin E. Chang, N. Lynn Henry, M.L. Dodson, Michael Newman, Ankita Date +3 more

Acute Toxicity in SWOG 1706, a Randomized Trial Comparing Radiotherapy for Inflammatory Breast Cancer with and without Concurrent Olaparib

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.1169

N/A

0DataRank · unranked

0 citations

Allison Meisner, Pavani Chalasani, W. Barlow, Jennifer R. Bellon, N. Lynn Henry +14 more

Impact of the Integrative Oncology Scholars Program on Oncology Providers’ Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology Care

UNC Libraries(2025)10.17615/7yw1-st24

N/A

0DataRank · unranked

0 citations

Judith M. Fouladbakhsh, Suzanna M. Zick, Eleanor Walker, Brad Zebrack, Sabrina Mayhew +8 more

Data from Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

(2023)10.1158/1078-0432.c.6523959

N/A

0DataRank · unranked

0 citations

Amanda L. Blackford, Anne Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich +12 more

Predictive model of aromatase inhibitor non-adherence using patient-reported outcomes in women with breast cancer (SWOG S1105).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12019

N/A

0DataRank · unranked

3 citations

Anna Moseley, Kathryn B. Arnold, Grace Clarke Hillyer, Julie R. Gralow, N. Lynn Henry +4 more

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

UNC Libraries(2020)10.17615/6adk-r027

N/A

0DataRank · unranked

0 citations

Carey K. Anders, Charles M. Perou, Ian E. Krop, Constance Cirrincione, Brandelyn N. Pitcher +13 more

Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab022

N/A

0DataRank · unranked

26 citations

Alfred I. Neugut, Anna Moseley, Kathryn B. Arnold, Julie R. Gralow, N. Lynn Henry +4 more

Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer

Breast Cancer Research and Treatment(2021)10.1007/s10549-020-06071-w

N/A

0DataRank · unranked

5 citations

Xuechen Wang, Danielle Zimmerman, Lindsay Burt, Benjamin Haaland, N. Lynn Henry +1 more

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps3618

N/A

0DataRank · unranked

7 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Long-term results from a randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in early stage breast cancer (S1200).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12018

N/A

0DataRank · unranked

2 citations

Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke +5 more

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

BMC Medical Research Methodology(2021)10.1186/s12874-021-01368-w

N/A

0DataRank · unranked

0 citations

Gillian Gresham, Sungjin Kim, Michael Luu, N. Lynn Henry, Mourad Tighiouart +4 more

Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10527

Top 100%

0DataRank

Top 100%0 citations

Yi‐Mi Wu, Dan R. Robinson, James M. Rae, N. Lynn Henry, Daniel F. Hayes +9 more

Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing

British Journal of Clinical Pharmacology(2022)10.1111/bcp.15244

N/A

0DataRank · unranked

18 citations

Li Chen, N. Lynn Henry, Jennifer J. Griggs, Daniel F. Hayes, Brian A. Derstine +4 more

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

npj Breast Cancer(2022)10.1038/s41523-022-00489-9

N/A

0DataRank · unranked

9 citations

Sungjin Kim, Ron D. Hays, Márcio A. Diniz, Mourad Tighiouart, Gillian Gresham +6 more

Unintended Negative Consequences of Managing Chemotherapy Toxicity

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac174

N/A

0DataRank · unranked

2 citations

Patricia A. Ganz, N. Lynn Henry

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms

Research Square(2022)10.21203/rs.3.rs-1315678/v1

N/A

0DataRank · unranked

5 citations

Julie A. Douglas, Robert M. Miller, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta +7 more

Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3647

N/A

0DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Co-occurrence and Metabolic Biomarkers of Sensory and Motor Subtypes of Peripheral Neuropathy from Paclitaxel

Research Square(2022)10.21203/rs.3.rs-1251386/v1

N/A

0DataRank · unranked

1 citations

Elizabeth Smith, Kathleen A. Stringer, N. Lynn Henry, Daniel L. Hertz, Ciao-Sin Chen

Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients

Research Square(2022)10.21203/rs.3.rs-2110059/v1

N/A

0DataRank · unranked

1 citations

Grant Carr, Sidi Wang, Chad M. Brummett, Kelley M. Kidwell, N. Lynn Henry +1 more

Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12094

N/A

0DataRank · unranked

0 citations

John Devin Peipert, Vered Stearns, Victor T. Chang, Opeyemi A. Jegede, Edward H. Ip +15 more

Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6568

N/A

0DataRank · unranked

0 citations

Kelley M. Kidwell, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, N. Lynn Henry +1 more

Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12024

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Dawn L. Hershman, Amy K. Darke, Daniel L. Hertz, Thomas H. Brannagan +8 more

Breast cancer survivorship and sexual dysfunction: a population-based cohort study

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-06953-9

N/A

0DataRank · unranked

26 citations

Tiffany Ho, John Snyder, Mark Dodson, Vikrant Deshmukh, Michael Newman +4 more

Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

Cancer Prevention Research(2023)10.1158/1940-6207.capr-23-0216

N/A

0DataRank · unranked

4 citations

N. Lynn Henry, Ron D. Hays, Sungjin Kim, Michael Luu, Márcio A. Diniz +7 more

Risk of Toxicity From Topical 5‐Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.3131

N/A

0DataRank · unranked

3 citations

Amy L. Pasternak, N. Lynn Henry, Vaibhav Sahai, Daniel L. Hertz, J. Quesada Granados

Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12003

N/A

0DataRank · unranked

11 citations

Joseph M. Unger, Dawn L. Hershman, Amy K. Darke, Daniel L. Hertz, Thomas H. Brannagan +9 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps258

N/A

0DataRank · unranked

1 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Genetic Variation in Charcot–Marie–Tooth Genes Contributes to Sensitivity to Paclitaxel-Induced Peripheral Neuropathy

Pharmacogenomics(2020)10.2217/pgs-2020-0053

N/A

0DataRank · unranked

14 citations

Fang Fang, Kelley M. Kidwell, Kiran Vangipuram, Lauren A. Marcath, Christina L. Gersch +7 more

PHASE II/III STUDY OF R‐MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS

Hematological Oncology(2023)10.1002/hon.3166_ot27

N/A

0DataRank · unranked

0 citations

H. Li, Anne Beaven, Paolo F. Caimi, Leandro Cerchietti, Rebecca L. Olin +9 more

Adverse Health Outcomes among Rural and Urban Breast Cancer Survivors: A Population-Based Cohort Study

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0421

Top 100%

0DataRank

Top 100%0 citations

Bayarmaa Mark, Chun-Pin E. Chang, Shane Lloyd, M.L. Dodson, Vikrant Deshmukh +8 more

ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer

JCI Insight(2024)10.1172/jci.insight.177759

N/A

0DataRank · unranked

21 citations

Qing Kang, Daniel H. Hovelson, Erin Sandford, Mary Olesnavich, Sarah M. Dermody +23 more

N. Lynn Henry

Indexed papers

Top data-sharing exemplar

Papers